The US Food and Drug Administration (FDA) said in a statement that the pharmaceutical company Johnson & Johnson’s single-dose Covid-19 vaccine was safe and effective in trials.
The Food and Drug Administration, which pointed out that the way has been opened for the approval of the vaccine, which will be discussed for emergency use on Friday, had previously performed the same procedure without giving emergency use to Biontech-Pfizer and Moderna vaccines.
APPLY A SINGLE DOSE, 66 PERCENT EFFECTIVE
US-based pharmaceutical company Johnson & Johnson announced that the percentage of effectiveness of the single-dose single vaccine they developed against Covid-19 in the world was 66 percent.
Johnson & Johnson said in a statement that the vaccine developed was effective against mild and severe cases, and in studies conducted on approximately 44 thousand people, the vaccine was effective at 72 percent in the USA, 66 percent in Latin America and 57 percent in South Africa.
SHOW ITS EFFECT AFTER 28 DAYS
Stating that none of the subjects died in the studies, Johnson & Johnson is the only company that tests mutations. It was announced that Johnson & Johnson’s vaccine, which became effective 28 days after being injected, was 85 percent effective in severe Covid-19 cases.